VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Conditions: Chronic Hepatitis B Interventions: Drug: VIR-2218 and peginterferon alfa-2a Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials